Published in Nat Genet on September 01, 2000
Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet (2010) 10.71
A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A (2006) 10.63
Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev (2002) 6.74
Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol (2001) 5.61
Large-scale structure of genomic methylation patterns. Genome Res (2005) 4.11
Toucan: deciphering the cis-regulatory logic of coregulated genes. Nucleic Acids Res (2003) 3.68
Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin (2013) 2.93
A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. Genome Res (2004) 2.56
Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One (2010) 2.55
CG dinucleotide clustering is a species-specific property of the genome. Nucleic Acids Res (2007) 2.48
Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One (2009) 2.29
Predicting aberrant CpG island methylation. Proc Natl Acad Sci U S A (2003) 2.25
CpGcluster: a distance-based algorithm for CpG-island detection. BMC Bioinformatics (2006) 2.19
Determinants of CpG islands: expression in early embryo and isochore structure. Genome Res (2001) 2.07
Performance assessment of promoter predictions on ENCODE regions in the EGASP experiment. Genome Biol (2006) 2.02
CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res (2005) 1.89
Generic eukaryotic core promoter prediction using structural features of DNA. Genome Res (2007) 1.80
Identification of plant promoter constituents by analysis of local distribution of short sequences. BMC Genomics (2007) 1.77
Comprehensive analysis of the base composition around the transcription start site in Metazoa. BMC Genomics (2004) 1.68
Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates. Elife (2013) 1.63
Evolutionary turnover of mammalian transcription start sites. Genome Res (2006) 1.51
Computational approaches to identify promoters and cis-regulatory elements in plant genomes. Plant Physiol (2003) 1.50
Determining promoter location based on DNA structure first-principles calculations. Genome Biol (2007) 1.44
Transcription induces strand-specific mutations at the 5' end of human genes. Genome Res (2008) 1.41
Transcriptional features of genomic regulatory blocks. Genome Biol (2009) 1.37
MPromDb: an integrated resource for annotation and visualization of mammalian gene promoters and ChIP-chip experimental data. Nucleic Acids Res (2006) 1.28
Meta-analysis discovery of tissue-specific DNA sequence motifs from mammalian gene expression data. BMC Bioinformatics (2006) 1.28
A clustering property of highly-degenerate transcription factor binding sites in the mammalian genome. Nucleic Acids Res (2006) 1.21
Tissue-specific variation in DNA methylation levels along human chromosome 1. Epigenetics Chromatin (2009) 1.19
Differentiation of core promoter architecture between plants and mammals revealed by LDSS analysis. Nucleic Acids Res (2007) 1.19
A ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response. Nucleic Acids Res (2009) 1.16
Dragon gene start finder: an advanced system for finding approximate locations of the start of gene transcriptional units. Genome Res (2003) 1.15
Begin at the beginning: predicting genes with 5' UTRs. Genome Res (2005) 1.14
DNA methylation data analysis and its application to cancer research. Epigenomics (2013) 1.14
Dynamics of DNA methylation in aging and Alzheimer's disease. DNA Cell Biol (2012) 1.13
CpG islands or CpG clusters: how to identify functional GC-rich regions in a genome? BMC Bioinformatics (2009) 0.98
CpG_MI: a novel approach for identifying functional CpG islands in mammalian genomes. Nucleic Acids Res (2009) 0.98
Do Alu repeats drive the evolution of the primate transcriptome? Genome Biol (2008) 0.96
Systematic clustering of transcription start site landscapes. PLoS One (2011) 0.95
MetaProm: a neural network based meta-predictor for alternative human promoter prediction. BMC Genomics (2007) 0.94
Dragon Gene Start Finder identifies approximate locations of the 5' ends of genes. Nucleic Acids Res (2003) 0.94
Leishmania donovani infection causes distinct epigenetic DNA methylation changes in host macrophages. PLoS Pathog (2014) 0.92
Putative zinc finger protein binding sites are over-represented in the boundaries of methylation-resistant CpG islands in the human genome. PLoS One (2007) 0.90
Meta-analysis of human methylomes reveals stably methylated sequences surrounding CpG islands associated with high gene expression. Epigenetics Chromatin (2014) 0.89
Tight associations between transcription promoter type and epigenetic variation in histone positioning and modification. BMC Genomics (2011) 0.89
A composite method based on formal grammar and DNA structural features in detecting human polymerase II promoter region. PLoS One (2013) 0.88
Role of CpG context and content in evolutionary signatures of brain DNA methylation. Epigenetics (2011) 0.86
Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches. Epigenetics (2010) 0.83
DNA demethylation by 5-aza-2'-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences. Epigenetics Chromatin (2015) 0.83
DNA methylation dynamics in muscle development and disease. Front Aging Neurosci (2015) 0.83
Towards a genome-wide reconstruction of cis-regulatory networks in the human genome. Semin Cell Dev Biol (2009) 0.83
Eukaryotic genomes may exhibit up to 10 generic classes of gene promoters. BMC Genomics (2012) 0.83
Epigenetic profile of the euchromatic region of human Y chromosome. Nucleic Acids Res (2011) 0.81
Genomic landscape of human, bat, and ex vivo DNA transposon integrations. Mol Biol Evol (2014) 0.81
Epigenetics advancing personalized nanomedicine in cancer therapy. Adv Drug Deliv Rev (2012) 0.80
Disagreement between two common biomarkers of global DNA methylation. Clin Epigenetics (2016) 0.80
Profiling ascidian promoters as the primordial type of vertebrate promoter. BMC Genomics (2011) 0.79
Effects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet (2014) 0.79
A hybrid neural network system for prediction and recognition of promoter regions in human genome. J Zhejiang Univ Sci B (2005) 0.78
Quantitative leukocyte BDNF promoter methylation analysis in bipolar disorder. Int J Bipolar Disord (2013) 0.77
Identification of CpG islands in DNA sequences using statistically optimal null filters. EURASIP J Bioinform Syst Biol (2012) 0.77
DNA methylation and DNA methyltransferases. Epigenetics Chromatin (2017) 0.75
Demethylation treatment restores erectile function in a rat model of hyperhomocysteinemia. Asian J Androl (2016) 0.75
DNA methylation profiling of the fibrinogen gene landscape in human cells and during mouse and zebrafish development. PLoS One (2013) 0.75
A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers. Sci Rep (2017) 0.75
Genomic regions with distinct genomic distance conservation in vertebrate genomes. BMC Genomics (2009) 0.75
Comparative genetic analysis of the 45S rDNA intergenic spacers from three Saccharum species. PLoS One (2017) 0.75
Connecting the Dots Between Fatty Acids, Mitochondrial Function, and DNA Methylation in Atherosclerosis. Curr Atheroscler Rep (2017) 0.75
Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell (1998) 62.20
SCPD: a promoter database of the yeast Saccharomyces cerevisiae. Bioinformatics (1999) 6.79
Computational identification of promoters and first exons in the human genome. Nat Genet (2001) 5.88
Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol (2001) 5.61
A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet (2001) 5.02
Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol Cell Biol (2000) 3.01
TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res (2007) 2.67
Detection of polyadenylation signals in human DNA sequences. Gene (1999) 2.66
Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. Genome Res (2001) 2.66
Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. J Mol Biol (2001) 2.56
An alternative-exon database and its statistical analysis. DNA Cell Biol (2000) 2.51
Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing. EMBO J (1999) 2.20
CART classification of human 5' UTR sequences. Genome Res (2000) 1.75
A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res (1994) 1.50
Periodical distribution of transcription factor sites in promoter regions and connection with chromatin structure. Proc Natl Acad Sci U S A (1999) 1.16
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene (2011) 1.13
Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol (2001) 1.05
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors. Curr Med Chem (2000) 1.01
Cluster, function and promoter: analysis of yeast expression array. Pac Symp Biocomput (2000) 1.00
[Studies on the constituents of Artemisia annua L. (author's transl)]. Yao Xue Xue Bao (1981) 0.97
Influence of N substitution on antimycobacterial activity of ciprofloxacin. Antimicrob Agents Chemother (1990) 0.95
The intestine as a model for neuronal plasticity. Arch Histol Cytol (1989) 0.87
Identifying the 3'-terminal exon in human DNA. Bioinformatics (2001) 0.86
Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists. J Med Chem (1998) 0.85
Pombe: a gene-finding and exon-intron structure prediction system for fission yeast. Yeast (1998) 0.82
VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities. Jpn J Pharmacol (2001) 0.80
Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists. J Med Chem (1997) 0.79
Development of a three-dimensional CysLT1 (LTD4) antagonist model with an incorporated amino acid residue from the receptor. J Med Chem (1998) 0.78
Hypertrophy of rat sensory ganglion neurons following intestinal obstruction. Gastroenterology (1993) 0.78
Histamine H1 receptor ligands. Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology. Farmaco (1999) 0.78
Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix. Oncol Lett (2011) 0.77
Histamine H1 receptor ligands: part II. Synthesis and in vitro pharmacology of 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4-yl)ethanamine derivatives. Farmaco (2001) 0.75
[Clinical significance of tomography in congenital atresia of the external acoustic meatus]. Zhonghua Fang She Xue Za Zhi (1987) 0.75
Studies of qingyangshen (root of Cynanchum otophyllum). III. Effect of qingyangshen on acetylcholine concentration in mouse brain. J Tradit Chin Med (1985) 0.75
[Studies on the introduction and cultivation of Kaempferia galanga L]. Zhongguo Zhong Yao Za Zhi (1989) 0.75
Silencing ECHS1 attenuates the proliferation and induces the autophagy of hepatocellular carcinoma via impairing cell metabolism and activating AMPK. Neoplasma (2015) 0.75
Studies of qingyangshen (root of Cynanchum otophyllum). I. Effect of qingyangshen on copper and zinc metabolism. J Tradit Chin Med (1985) 0.75
[A biogenetic synthesis of prostaglandin E1 methyl ester]. Yao Xue Xue Bao (1986) 0.75
[A major histocompatibility complex class Ⅱ deficiency case report and literature review]. Zhonghua Er Ke Za Zhi (2016) 0.75
[Discussion on the errors of tomography (author's transl)]. Zhonghua Fang She Xue Za Zhi (1980) 0.75
[Estimation of some entomological parameters in relation to the transmission of bancroftian filariasis]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (1987) 0.75
Hemoglobin GuiZhou or alpha 277(EF6)Pro----Arg beta 2, a new slow-moving hemoglobin variant observed in China. Hemoglobin (1984) 0.75
Synthesis of antibacterial 4-quinolone-3-carboxylic acids and their derivatives. Part 2. Pharmazie (1991) 0.75
Experiences in the treatment of electrical burns covering deep wounds with various tissue flaps. Acta Chir Plast (1989) 0.75